相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Hot flush symptom-free days with bazedoxifene/conjugated estrogens in postmenopausal women
H. Yu et al.
CLIMACTERIC (2013)
Effects of bazedoxifene/conjugated estrogens on endometrial safety and bone in postmenopausal women
S. Mirkin et al.
CLIMACTERIC (2013)
Health-related quality of life of women with menopausal hot flushes and night sweats
B. Ayers et al.
CLIMACTERIC (2013)
Tissue selective estrogen complex combinations with bazedoxifene/conjugated estrogens as a model
J. V. Pinkerton et al.
CLIMACTERIC (2013)
Inhibitory Effects of a Bazedoxifene/Conjugated Equine Estrogen Combination on Human Breast Cancer Cells In Vitro
Yan Song et al.
ENDOCRINOLOGY (2013)
Pharmacokinetic evaluation of bazedoxifene for the treatment of osteoporosis
Davide Gatti et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2013)
Bazedoxifene plus conjugated estrogens in HT for the prevention of osteoporosis and treatment of vasomotor symptoms associated with the menopause
Sri Harsha Tella et al.
EXPERT OPINION ON PHARMACOTHERAPY (2013)
Menopausal Hormone Therapy and Health Outcomes During the Intervention and Extended Poststopping Phases of the Women's Health Initiative Randomized Trials
JoAnn E. Manson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
Tissue-selective estrogen complexes for postmenopausal women
Sebastian Mirkin et al.
MATURITAS (2013)
Endometrial profile of bazedoxifene acetate alone and in combination with conjugated equine estrogens in a primate model
Kelly F. Ethun et al.
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY (2013)
Breast Effects of Bazedoxifene-Conjugated Estrogens A Randomized Controlled Trial
JoAnn V. Pinkerton et al.
OBSTETRICS AND GYNECOLOGY (2013)
Tissue Selective Estrogen Complexes (TSECs) Differentially Modulate Markers of Proliferation and Differentiation in Endometrial Cells
Jaime Kulak et al.
REPRODUCTIVE SCIENCES (2013)
Global Profiling of TSEC Proliferative Potential by the Use of a Reporter Mouse for Proliferation
Paolo Oliva et al.
REPRODUCTIVE SCIENCES (2013)
Profile of bazedoxifene/conjugated estrogens for the treatment of estrogen deficiency symptoms and osteoporosis in women at risk of fracture
Maurizio Rossini et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2013)
Effects of the Conjugated Equine Estrogen/Bazedoxifene Tissue-Selective Estrogen Complex (TSEC) on Mammary Gland and Breast Cancer in Mice
Yan Song et al.
ENDOCRINOLOGY (2012)
The Tissue Selective Estrogen Complex: A Novel Approach to the Treatment of Menopausal Symptoms
Risa Kagan
JOURNAL OF WOMENS HEALTH (2012)
Research Resource: Transcriptional Profiling in a Cellular Model of Breast Cancer Reveals Functional and Mechanistic Differences Between Clinically Relevant SERM and Between SERM/Estrogen Complexes
Suzanne E. Wardell et al.
MOLECULAR ENDOCRINOLOGY (2012)
Using bazedoxifene plus conjugated estrogens for treating postmenopausal women: a comprehensive review
Hugh S. Taylor et al.
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY (2012)
The 2012 Hormone Therapy Position Statement of The North American Menopause Society
[Anonymous]
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY (2012)
Effect of hormone replacement therapy on cardiovascular events in recently postmenopausal women: randomised trial
Louise Lind Schierbeck et al.
BMJ-BRITISH MEDICAL JOURNAL (2012)
Skeletal effects of bazedoxifene paired with conjugated estrogens in ovariectomized rats
Barry S. Komm et al.
BONE (2011)
The Selective Estrogen Receptor Modulator Bazedoxifene Inhibits Hormone-Independent Breast Cancer Cell Growth and Down-Regulates Estrogen Receptor α and Cyclin D1
Joan S. Lewis-Wambi et al.
MOLECULAR PHARMACOLOGY (2011)
Effects of bazedoxifene/conjugated estrogens on quality of life in postmenopausal women with symptoms of vulvar/vaginal atrophy
G. Bachmann et al.
CLIMACTERIC (2010)
Tissue-Selective Estrogen Complexes A Promising Option for the Comprehensive Management of Menopausal Symptoms
David F. Archer
DRUGS & AGING (2010)
Estrogen, cytokines, and pathogenesis of postmenopausal osteoporosis
Roberto Pacifici
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
A randomized, placebo- and active-controlled trial of bazedoxifene/conjugated estrogens for treatment of moderate to severe vulvar/vaginal atrophy in postmenopausal women
Risa Kagan et al.
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY (2010)
Effects of Various Selective Estrogen Receptor Modulators with or without Conjugated Estrogens on Mouse Mammary Gland
Bryan J. Peano et al.
ENDOCRINOLOGY (2009)
Evaluation of bazedoxifene/conjugated estrogens for the treatment of menopausal symptoms and effects on metabolic parameters and overall safety profile
Rogerio A. Lobo et al.
FERTILITY AND STERILITY (2009)
Bazedoxifene/conjugated estrogens (BZA/CE): incidence of uterine bleeding in postmenopausal women
David E. Archer et al.
FERTILITY AND STERILITY (2009)
Efficacy of tissue-selective estrogen complex of bazedoxifene/conjugated estrogens for osteoporosis prevention in at-risk postmenopausal women
Robert Lindsay et al.
FERTILITY AND STERILITY (2009)
Endometrial effects of a tissue selective estrogen complex containing bazedoxifene/conjugated estrogens as a menopausal therapy
James H. Pickar et al.
FERTILITY AND STERILITY (2009)
Bazedoxifene/conjugated estrogens and quality of life in postmenopausal women
Wulf Utian et al.
MATURITAS (2009)
Relief of vasomotor symptoms with the tissue-selective estrogen complex containing bazedoxifene/conjugated estrogens: a randomized, controlled trial
JoAnn V. Pinkerton et al.
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY (2009)
Symptoms of menopause: Hot flushes
Nanette Santoro
CLINICAL OBSTETRICS AND GYNECOLOGY (2008)
The Pairing of a Selective Estrogen Receptor Modulator, Bazedoxifene, with Conjugated Estrogens as a New Paradigm for the Treatment of Menopausal Symptoms and Osteoporosis Prevention
Yogendra Kharode et al.
ENDOCRINOLOGY (2008)
Efficacy of Bazedoxifene in Reducing New Vertebral Fracture Risk in Postmenopausal Women With Osteoporosis: Results From a 3-Year, Randomized, Placebo-, and Active-Controlled Clinical Trial
Stuart L. Silverman et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2008)
Effects of bazedoxifene on BMD and bone turnover in postmenopausal women: 2-yr results of a randomized, double-blind, placebo-, and active-controlled study
Paul D. Miller et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2008)
Bazedoxifene and bazedoxifene combined with conjugated estrogens for the management of postmenopausal osteoporosis
E. Michael Lewiecki
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2007)
The effects of combined raloxifene and oral estrogen on vasomotor symptoms and endometrial safety
Dale W. Stovall et al.
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY (2007)
MRI-measured bone marrow adipose tissue is inversely related to DXA-measured bone mineral in Caucasian women
W. Shen et al.
OSTEOPOROSIS INTERNATIONAL (2007)
Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes - The NSABP study of tamoxifen and raloxifene (STAR) P-2 trial
Victor G. Vogel et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Bazedoxifene acetate: A selective estrogen receptor modulator with improved selectivity
BS Komm et al.
ENDOCRINOLOGY (2005)
Endometrial effects of bazedoxifene acetate, a novel selective estrogen receptor modulator, in postmenopausal women
S Ronkin et al.
OBSTETRICS AND GYNECOLOGY (2005)
Further psychometric property development of the Menopause-Specific Quality of Life questionnaire and development of a modified version, MENQOL-Intervention questionnaire
JE Lewis et al.
MATURITAS (2005)
Transition from estrogen therapy to raloxifene in postmenopausal women: effects on treatment satisfaction and the endometrium - a pilot study
SR Davis et al.
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY (2004)
Effects of estrogen plus progestin on risk of fracture and bone mineral density - The Women's Health Initiative randomized trial
JA Cauley et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Bazedoxifene acetate metabolic disposition in healthy, postmenopausal women.
A Chandrasekaran et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2003)
Bazedoxwene acetate dose proportionality in healthy, postmenopausal women.
J Ermer et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2003)
Risks and benefits of estrogen plus progestin in healthy postmenopausal women - Principal results from the Women's Health Initiative randomized controlled trial
JE Rossouw et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
Is there a menopausal syndrome? Menopausal status and symptoms across racial/ethnic groups
NE Avis et al.
SOCIAL SCIENCE & MEDICINE (2001)
Recent insights into the varying activity of estrogens
M Dey et al.
MATURITAS (2000)
分享论文
